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Abstract: Radiation dose is an important performance indicator of a dedicated breast CT (DBCT). In this paper, the method of 
putting thermoluminescent dosimeters (TLD) into a breast shaped PMMA phantom to study the dose distribution in breasts was 
improved by using smaller TLDs and a new half-ellipsoid PMMA phantom. Then the weighted CT dose index (CTDIw) was 
introduced to average glandular assessment in DBCT for the first time and two measurement modes were proposed for different 
sizes of breasts. The dose deviations caused by using cylindrical phantoms were simulated using the Monte Carlo method and a 
set of correction factors were calculated. The results of the confirmatory measurement with a cylindrical phantom (11cm/8cm) 
show that CTDIw gives a relatively conservative overestimate of the average glandular dose comparing to the results of Monte 
Carlo simulation and TLDs measurement. But with better practicability and stability, the CTDIw is suitable for dose evaluations in 
daily clinical practice. Both of the TLDs and CTDIw measurements demonstrate that the radiation dose of our DBCT system is 
lower than conventional two-view mammography.  
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1 Introduction 
Breast cancer is the most common malignancy in 
women, causing the death of hundreds of thousands of 
women, and the morbidity rate is increasing year by year. 
The early diagnosis and treatment of breast cancer is 
important for prognosis, improving the quality of 
patients’ life and reducing the cost of treatment. DBCT 
overcomes the shortcomings of many other breast 
examination methods: the X-ray of DBCT doesn't 
penetrate the chest cavity as in conventional CT so won’t 
produce additional doses; breasts are not compressed in 
the examination of DBCT and patients may feel more 
comfortable than mammography; and the 
three-dimensional images of the breast structure in the 
natural state overcome overlap of breast tissues in 
mammography, so images of DBCT can accurately 
display the locations, shapes, number and sizes of the 
breast lesions, which is helpful to distinguishing benign 
breast tumors from malignant ones when it is combined 
with the observation of other features of tumor , for 
example, whether it has metastasized; besides, DBCT can 
guide biopsy for clinicopathologic analysis. For 
radioactive diagnostic equipments, the radiation dose is 
an important criterion to evaluate their security, and the 
potential radiation damage must be strictly controlled. 
DBCT is no exception, good image quality of which is 
meaningful only when the radiation dose is in safe range. 
For any method attempting to improve the image quality 
such as changing geometry, scanning mode of DBCT 
system, optimizing experimental parameters and so on, 
the prerequisite of which is that the radiation dose should 
not be increased. So methods that can evaluate the 
radiation dose accurately and objectively are needed in 
the process of debugging and running of DBCT. At 
present, Monte Carlo simulations and experiments are the 
two main ways to study the absorbed dose in breast tissue. 
Through Monte Carlo simulations, any factors affecting 
the image quality such as the size, shape and material of 
phantoms, system geometry and tube voltage and current 
can be calculated separately [1, 2], but the simulation 
results need to be verified by experiments. Russo et al 
examined dose distribution by placing TLDs in a 
half-ellipsoid polymethyl methacrylate (PMMA) 
phantom [3], whose results showed that the DBCT 
delivered a more uniform dose to breasts, so the risk is 
minor for patients relative to mammography. But the size 
of TLDs they used is relative large (3mm × 3mm × 
0.9mm) to the size of phantom and three TLDs were 
  
located each of the six cavities, which is bound to 
increase the influence on primary dose distribution in 
phantom. Furthermore, the positions of breasts in 
examination and the radiation dose in chest wall are not 
considered during their measurements. The ionization 
chamber has been used to measure the absolute dose in 
DBCT. Boone et al used the ionization chamber to 
measure the air karma at the isocenter of a cylindrical 
phantom and calculated the average glandular dose by 
multiplying the normalized glandular dose coefficients 
for CT (DgNCT) calculated by Monte Carlo simulations 
[4]. But the shapes of cylindrical phantoms are different 
from breasts, so dose calculation deviationss may be 
inevitable. 
In this paper, two experimental methods were 
carried out to study the radiation dose of DBCT. On one 
hand, we improved the TLDs dose measurement method 
and smaller size of cylindrical TLDs and a half-ellipsoid 
phantom with cavities in the breast and chest wall part 
were used. On the other hand, the standard dose 
evaluation method in conventional CT, CTDIw, was 
introduced to the DBCT dose measurement for the first 
time. The dose differences caused by using cylindrical 
phantoms, which are different from the half-ellipsoid 
shape of the breast, were calculated by Monte Carlo 
simulations and correction factors of CTDIw were given 
corresponding to different breast sizes to avoid 
underestimating the real dose in breasts. 
2 Materials and methods 
2.1 DBCT system  
The X-ray tube used in our DBCT system operates 
between 5kV and 75 kV with a current range of 0-17.5 
mA, which has a tungsten anode with a minimum focal 
spot size of 1.0mm and an inherent filtration of 0.8mm 
Be. The flat panel detector used in DBCT is the Varian 
PaxScan 2520D/CL, the size and resolution of which are 
suitable to breast imaging. The X-ray tube and detector 
were coupled to the slip ring at a certain relative position 
to constitute the main structure of DBCT system. Table 1 
shows the operation conditions of DBCT determined in 
early work under which good images quality can be 
obtained. 
Table 1. DBCT geometry and operation parameters 
Source angle α About 15° 
  SOD 60cm 
Tube voltage 70kV 
Tube current 8mA 
Additive filter 8mm Al 
Exposure time 15s 
Projections 450 
2.2 Dosimeters and phantoms 
A group of 36 TLDs (LiF: Mg, Cu, P, 
Φ1.5mm×0.8mm) as shown in Fig.1 (a) were used for 
dose distribution measurements. The breast phantom still 
has a shape of half-ellipsoid composed by two halves of 
block machined from one PMMA cylinder of 14cm 
diameter (Fig. 1(b)), which has a 8cm half-ellipsoid 
breast part, a 3cm cylindrical chest wall part and a 2.5cm 
auxiliary suspension structure. A total of 18 TLDs were 
placed in the breast part and 15 TLDs in the chest wall 
part, so dose of these two parts can be measured at the 
same time. 
The phantom used for CTDIw measuring 
experiments has a cylindrical shape and PMMA material 
similar to the standard CTDI phantom used in the 
conventional CT as shown in Fig.1(c) , but has a length 
of 13cm and a diameter of 11cm so that the result can be 
compared with TLDs experiment. The CTDIw phantom 
has a hole in the isocenter and 8 holes at the periphery 
where ionization chambers can be put, and there were
 (a)                         (b)                       (c) 
Fig. 1. (a) TLDs used in dose distribution measurement. (b) The half-ellipsoid phantom used in TLDs measurement experiment. (c) The 
cylindrical phantom used in CTDIw measurement experiment.
  
also 9 PMMA sticks can be used to fill the rest holes 
during measurement. The length of the ionization 
chamber used here is a standard 10cm (PTW, Freiburg, 
Germany), which can perform the dose integration 
process in measurements and get values in mGy·cm to be 
used for CTDI calculation. 
2.3 TLDs dose measurements  
TLDs are commonly used to measure the absorbed 
dose inside phantoms in dosimetry measurements 
because they can be made into different shapes and sizes. 
In this paper, we followed the standardized processing 
procedures given in [5] and selected 36 pieces with the 
best homogeneity and reproducibility from 300 TLDs for 
dose measuring. Then, the monoenergetic gamma beam 
(Cs-137) was used to calibrate the TLDs because the 
radiation dose in every exposure can be controlled easily 
and accurately. TLDs were exposed under the dose of 
1mGy, 6mGy, 10mGy, 15mGy and 20mGy respectively 
in calibrations, and 24 hours later the 36 TLDs were read 
and annealed after each exposure. But the energy 
response differences of TLDs must be considered here 
because different effective energies of beams were used 
in calibration (622keV) and measurement (40keV). 
According to the energy response curve given by 
manufacturer, luminous efficiency of LiF: Mg, Cu, P at 
40keV is about 1.5 times higher than at 622keV, so all 
the readouts in calibrations should be given a correction 
factor of 1.5 when plotting the relation curve at 
40keV.The overall relative standard deviation of the 36 
TLDs is about 10.0%, including the errors due to 
dosimeters screening and calibration. In this way, once 
we get the readouts of TLDs after exposure, the absorbed 
dose can be obtained with linear interpolation method 
base on the relation curve as shown in Fig. 2. 
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Fig. 2. TLDs dose response curve (effective energy of X-ray 
beam is 40 keV). 
In measurement, the phantom must be located at the 
right position to ensure the X-ray beam only irradiate the 
breast part of the half-ellipsoid phantom and the chest 
wall part is out of FOV of DBCT as in clinical practice. 
In that case, the dose in breast part is high and good 
image quality of breast can be obtained, but the dose of 
chest wall part is relatively low and the unnecessary dose 
of which can be avoided at the same time.  
2.4 CTDIw measurements and corrections 
CTDI measurements with the pencil chamber and 
two kinds of cylindrical phantoms, 16cm diameter for 
head and 32cm diameter for trunk, are the standard 
methods currently used in the dose assessment of 
conventional CT, which was proposed by Shapo et al in 
1981 for the first time [6], and has been adopted and 
defined by FDA, IEC, CEC, IAEA and other 
organizations. Leitz et al introduced a practical approach 
for measuring the average absorbed doses in CTDI 
PMMA phantoms and effective doses to the patients 
combining the tissue weighting factors of different parts 
of the body in 1995, assuming there is a linear decrease 
in dose between the periphery and the centre of the 
phantom [7]. In this method, five CTDI measurements 
were taken, one in the centre and four in the periphery of 
the CTDI phantom, then this five results were used to 
yield one CTDI value with the weighting factor of 1/3 for 
the centre CTDI and 2/3 for the averaged peripheral 
CTDI respectively, which was unified defined as the 
weighted CTDI (CTDIw) later. Comparison with the 
dose evaluations based on Monte Carlo simulations 
confirms the validity of this method. For a beam width W 
less than the length of the chamber L (10cm), CTDIw is 
given by the empirical equation [8]: 
1 2
( ) / ,
3 3
WCTDI Dcentre Dperiphery L W    (1)                    
Where Dcentre is the dose measured in the centre of the 
CTDI phantom and Dperiphery is the average of the doses 
measured at the outer symmetrical four chamber 
positions of the phantom. 
When the beam width W is greater than the length 
of the chamber L, W get the value of L, CTDIw is given 
by the empirical equation: 
1 2
.
3 3
WCTDI Dcentre Dperiphery          (2)                            
CTDIw was also used in dose assessment of cone 
beam CT system (CBCT) [9]. Amer et al believed that 
  
although CBCT is not a sequential, slice based technique, 
CTDI is impractical for measuring dose in CBCT, the 
standard 10cm chamber can continued be used to give a 
reasonable estimate of the dose in a certain region of 
CBCT FOV and the empirical equation (1) and (2) still 
can be used to calculate the CTDIw (CBDIw for CBCT). 
DBCT is a cone beam CT which images the breast in 
hundreds of directions in 360°, so this method is also 
suitable for DBCT dose measurement.     
Corresponding to different sizes of breasts, two 
ways of placing the phantom and the ionization chamber 
when measuring CTDIw in DBCT system were used as 
shown in Fig. 3. 
 
Fig. 3. The ways of placing the ionization chamber in the phantoms 
(central positions) when measuring CTDIw in DBCT system. (a): 
the exposed length of phantom is less than 10cm. (b): the exposed 
length of phantom is greater than 10cm. 
Due to the special half ellipsoid shape of the breast 
the dose estimates is consistently lower with cylindrical 
phantoms [2], so CTDIw should be corrected to 
maximize the accuracy of the measurements. In order to 
get the correction factors, dose simulation with half 
ellipsoid and cylindrical PMMA phantoms of different 
lengths (L) and diameters (D) were made respectively to 
give two groups of average glandular dose, then the dose 
ratios of the two groups were calculated to be used as the 
correction factors of CTDIw. In the simulation with half 
ellipsoid phantoms, we followed the way of constructing 
breast phantoms and used the X-ray spectrum (70kV, 
8mmAL filter) given in [10]. The results of two groups of 
simulation and the dose ratios are shown in Table 2.  
Although the simulation results of average glandular 
dose with cylindrical phantoms is only a little lower than 
that with half ellipsoid phantoms as listed in table 2, the 
corrected CTDIw by CFs can minimize the deviation of 
measurements to avoid dose underestimates in the 
process of debugging and running of the DBCT. 
Experiment was performed with a cylindrical breast 
phantom to verify the practicability of CTDIw in dose 
evaluation of the DBCT system. The phantom was placed 
in FOV of DBCT as shown in Fig. 3(a), and the CTDIw 
was calculated by empirical equation (1) with the 
W=8cm and L=10cm.  
3 Results 
3.1  Dose distribution in breast and chest wall 
TLDs were read 24 hours later after the half 
ellipsoid phantom was exposed, and readouts were 
converted into dose by linear interpolation according 
tothe TLDs dose response curve. Values obtained in the 
33 positions are shown in Fig. 4. The rapid decreasing of 
dose values between the breast and the chest wall
 
Table 2. The simulation results of average glandular dose with two shapes of breast phantoms. 
average glandular dose 
Gy per million photons(
-510 ) 
phantoms dose ratios 
(correction factors, CFs) cylindrical half-ellipsoid 
breast sizes 
(D/L) 
9cm/6cm 2.47 2.60 1.05 
10cm/7cm 2.44 2.48 1.02 
11cm/8cm 2.37 2.41 1.02 
12cm/9cm 2.35 2.40 1.02 
13cm/10cm 2.32 2.38 1.03 
14cm/11cm 2.22 2.36 1.06 
15cm/12cm 2.06 2.29 1.11 
  
confirmed the phantom was placed at the right place as 
described above. In the breast part, dose in both of the 
directions of the breast, radial and longitudinal, have a 
gradual increment, which is not exactly the same as the 
results of Russo et al, because of the consideration of 
phantom position in our measurement, but a more 
uniform dose distribution inside the breast obtained in 
DBCT examinations compared with that obtained in 
traditional mammography was observed in both of 
measurements. So if the same dose was delivered to 
breasts in one examination of mammography and DBCT, 
a more uniform dose distribution of the latter inside the 
breasts will be safer obviously. 
 
Fig 4. Doses obtained by TLDs in the 33 positions of the 
half-ellipsoid phantom (mGy). 
In order to give an estimation of the average 
glandular dose, the values of 13 TLDs in breast part of 
the phantom were averaged, and the result, 3.45mGy (the 
overall error is also 10%), can be regarded as a rough 
estimate of the average glandular dose in DBCT 
examination because of the low accuracy of TLDs in 
dose measurement. Even so, the average glandular dose 
obtained by TLDs can be used as a reference value for 
other dose measurement methods, for example the 
CTDIw used in this paper and the simulation methods. 
After the pencil ionization chamber was placed at the 
predetermined position as shown in Fig.3 (a), dose were 
read three times for each position and the average values  
 
were calculated to reduce the measuring deviations. 
Measurement results and the CTDIw calculated by 
empirical equation (1) were listed in Table 3. Then the 
CTDIw multiplied by the correction factors (CFs) 
corresponding to the size of breast (11cm/8cm) to get the 
estimation of average glandular dose. 
3.2 simulations of average glandular dose 
To further evaluate the validity of CTDIw, we 
compared it with the average glandular dose simulation 
result made by Tang et al using GATE (Geant 4 
application for tomographic emission) [10]. In their 
simulation of DBCT, half ellipsoid breast phantom with 
the material of 50% glandular and 50% adipose tissue 
covered by 3-5mm skin were used , which is similar to 
the real breast. Besides, monoenergetic X-ray beams 
were used in simulations to optimize the spectrum, the 
density different of glandular and adipose was also 
considered so the results were supposed to be credible 
and have a good reference value. According to the results 
obtained in [10], when the experiment conditions is the 
same as we used in this paper, for a breast of 11cm/8cm 
size, the average glandular dose per mAs is 2.95E-05Gy. 
So for a single scan of DBCT the overall dose is about 
3.54mGy obtained by 2.95E-05Gy multiplied by 120mAs 
(15s, 8mA). Besides, the different material must be taken 
into account when the dose results of experimental study 
and the simulation studies were compared with each 
other. According to the estimation in [3] of the 
discrepancies in absorbed dose due to the different 
materials (PMMA and 50-50 breast tissue), the value of 
ratio DPMMA with respect to D50-50 is about0.9 in the 
range of effective energies from 35.7 to 44.4 keV (which 
is 40keV for our beam). So we consider that the average 
glandular dose obtained by using PMMA in our 
measurement is about 10% less than that obtained 
byusing 50-50 breast tissue in simulations. The 
converted results of the two experimental studies and the 
simulation study by Tang et al are listed in Table 4. 
Table 3. The results of CTDI100 and CTDIw 
phantom 
(D/L) 
breast 
(D/L) 
100, peripheryCTDI  100, peripheryCTDI  100,cenrteCTDI  wCTDI  w
CF CTDI  
11cm/13cm 11cm/8cm 
31.2mGy•cm 
30.5mGy•cm 
31.0mGy•cm 
30.2mGy•cm 
32.0mGy·cm 26.3mGy·cm 3.65mGy 3.72mGy 
  
Table 4. The average glandular dose (AVG) of DBCT obtained by 
three methods (the breast size is 11cm/8cm) 
AVG/mGy 
Gate simulation 
(Tang et al.) 
TLDs wCTDI  
3.54(1) 3.84(1.08) 4.13(1.17) 
When comparing the three estimations of the 
average glandular dose, the agreement of two 
experimental results is found to be satisfactory generally 
when taking the measurement errors of TLDs into 
account. But both of the experimental measurements get 
higher results than the simulation, especially the CTDIw, 
which is about 17% higher than Gate results. There are 
many reasons for causing these errors. For simulation 
studies, estimation errors of the actual operating 
conditions of DBCT is inevitable, such as the X-ray 
spectrum, the irradiation flux of photons, the system 
geometry, the phantoms material and so on. Because the 
construction of simulation DBCT system tend to be 
idealized, so the result of which must be validated by 
experimental results. Besides, owing to the variability of 
TLDs, readouts of them may not be the same each time 
even after careful screening and accurate calibration. And 
after many times of irradiation and annealing, the TLDs 
became insensitive, which will cause small readouts and 
dose values. Then for the method of CTDIw proposed in 
this paper, there are also many factors can lead to errors. 
First, the empirical formula (1) and (2) is based on the 
assumption that the dose has a linear decrease in the 
radial direction of the cylindrical phantom, while the 
actual situation may not be like that. In addition, even 
after correction, the dose measurements using a 
cylindrical instead of half ellipsoidal phantom may cause 
errors because different shapes may cause different dose 
distribution in the phantoms. Finally, the effectiveness of 
CTDIw has always been controversial, because of using 
different range of integration and length of ionization 
chambers will get different results, and the most 
appropriate combinations have not been determined yet 
for different CT systems. In this paper, we used a 10cm 
ionization chamber and single phantom to measure 
CTDIw. So for the breast length less than 10cm, a part of 
the ionization chamber (2cm for the breast of 11cm/8cm 
size) is out of the FOV, where the dose we supposed to 
be zero. But as can be seen from Fig. 4, the chest wall 
part also has dose deposit because of the X-ray scattering, 
which will make CTDIw results calculated by the 
empirical formula (1) higher than virtually dose, and that 
is also the main reason why CTDIw get the highest result 
in three methods. In contrast, when the breast length is 
greater than 10cm, the CTDIw value is closely related to 
the position of ionization chamber in phantoms during 
measurement. Because for the FOV of our DBCT system 
using a half cone beam, radiation dose reduces from top 
to bottom on longitudinal [9], which means the CTDIw 
obtained in the upper 10 cm region of the FOV as shown 
in Fig. 3(b) is higher than that obtained across the whole 
exposed region of phantom. Therefore, in the the R & D 
process of DBCT, variety of methods should be used to 
study the radiation dose to ensure the accuracy of dose 
evaluation. However, once the DBCT system access to 
clinical trials or practical application, the CTDIw can be 
adopted as a standard method like in conventional CT for 
the assessment of average glandular dose in view of its 
usability and good stability. 
At present, conventional mammography is still the 
"Golden Standard" in the breast cancer diagnosis, and 
which has the specific limit of average glandular dose in 
examination. In the USA the guidelines of limitations to 
the maximum mean dose to the radiosensitive glandular 
tissue (MGD) delivered by a single view suggested by 
American College of Radiology (ACR) is 3mGy for a 
4.2cm thick compressed breast, consisting of 50% 
glandular and 50% adipose tissue, either for full field 
digital mammography or screen-film mammography[11]. 
Hence, DBCT can assume the average glandular dose of 
a two-view exam, 6mGy, as a reference limiting value for 
DBCT. In Europe, this reference limiting value of MGD 
is set as 5mGy for a two-view exam in mammography for 
an average compressed breast of 5.3cm [12]. To compare 
the DBCT with mammography on an equal-dose basis, 
the MGD to the single breast in DBCT imaging should be 
not higher than that (5-6mGy). As can be seen from the 
Table 4, either for U.S. or European standards, our DBCT 
system is safe under the current conditions. In Addition, 
the results obtained by TLDs indicate the dose 
distribution of DBCT is more uniform than 
mammography. The results in [13] obtained by Boone et 
al show that the parts of the breast where the X-ray beam 
penetrates can be several times the absorbed dose of the 
parts on the opposite side in mammography, so even the 
  
two systems give the same dose to patients, DBCT still is 
the safer one. 
 In this work, the radiation dose of our DBCT 
system was evaluated by experimental methods. The 
smaller TLDs and a new half ellipsoidal phantom with 
more cavities inside were used to measure the dose 
distribution in the breast and chest wall. Besides, the 
phantoms were set at a fixed position in measurement just 
like in clinical practice because different positions in 
FOV may affect the dose distribution in phantoms.  The 
results reconfirmed that DBCT delivered a more uniform 
dose distribution than mammography. Finally, an 
estimation of the average glandular dose was obtained by 
averaging the corrected values of TLDs by dose response 
curve of the breast part. On the other hand, for the first 
time we proposed to use the concept of CTDIw 
combining with a 10cm ionization chamber to evaluate 
the radiation dose of the dedicated breast CT systems, 
and two measurement modes were used for different size 
of breasts. A group of correction factors related to the 
different shapes of phantoms were calculated by Monte 
Carlo simulations for correcting the CTDIw to get the 
average glandular dose. Comparison with TLDs and Gate 
simulation results show that the CTDIw gives a useful, 
relatively conservative overestimate of the average 
glandular dose, but whose practicability and stability is 
better so it is suitable for dose assessment in clinical 
practice.  
Comparison with the dose limits of mammography 
shows that our DBCT system delivered a lower dose to 
patients when it obtains high quality 3-D images, that is 
to say there is still much potential room for DBCT to 
improve the image quality within the dose limits because 
a higher dose can bring better signal-to-noise ratio 
theoretically. 
In future studies, we should continue to work on 
improving the image quality of DBCT by changing the 
experiment conditions and reducing the patient dose at 
the same time. Furthermore, we will give CTDIw more 
accurate correction factors to assess the real dose of 
DBCT by analyzing the comprehensive factors that are 
influential in measurements of CTDIw in addition to the 
shape of phantoms, for example the different tube outputs, 
breast sizes and measurement modes using pencil 
chamber, so CTDIw can be served as the standard dose 
assessment method as in conventional CT in the future.
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